Security key
74449F209
PSYENCE BIOMEDICAL LTD. - Common Shares, without par value (PBM)
CUSIP: 74449F209
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Shares, without par value
- Total 13F shares
- 749,870
- Total 13F value
- $1,532,176
- Share change
- +567,547
- SEC-reported price per share
- $2.11
- Number of holders
- 11
- Value change
- +$1,147,474
- Number of buys
- 10
- Shares outstanding
- 4,527,832
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
11
Top holders
10
PBM full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2025
PSYENCE BIOMEDICAL LTD. SEC filings
PSYENCE BIOMEDICAL LTD. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74449F209
Recent filing periods:
Ownership snapshot
Top reported holders of PBM - PSYENCE BIOMEDICAL LTD. - Common Shares, without par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
AdvisorShares Trust
Disclosed value leader
AdvisorShares Investments...
Comparable rows
1/15
Latest evidence
31 Dec 2024
13D/G
13F
Lead comparable stake: 0.79%
14 rows are not safely comparable across share classes.
13D/G row: AdvisorShares Trust
Showing 1-6 of 15 holder rows.
Quick read
AdvisorShares Trust leads the comparable SEC ownership view at 0.79%.
1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens AdvisorShares Trust's linked filing trail.
Comparable ownership
Top 1
AdvisorShares Trust
0.79%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| AdvisorShares Trust |
13D/G
|
0.79%
|
$15,077
26,924 shares
|
$0 | 31 Dec 2024 |
| AdvisorShares Investments LLC |
13F
Company
|
—
class O/S missing
|
$123,238
1,232,376 shares
|
— | 30 Sep 2024 |
| CANTOR FITZGERALD, L. P. |
13F
Individual
|
—
mixed-class rows
|
$39,603
805,500 shares
mixed-class rows
|
— | 30 Sep 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
class O/S missing
|
$16,925
169,251 shares
|
— | 30 Sep 2024 |
| COWEN AND COMPANY, LLC |
13F
Company
|
—
class O/S missing
|
$15,384
1,220,986 shares
|
— | 30 Sep 2024 |
| Polar Asset Management Partners Inc. |
13F
Company
|
—
class O/S missing
|
$9,236
733,000 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
11
Shares
749,870
Rows available
11
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q2 2025 Across Filers
Q2 2025 holders
1
Q4 2024 holders
11
Holder diff
10
| Investor | Q2 2025 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q2 2025 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend